FDA's Elsa AI Tool Raises Accuracy and Oversight Concerns - Applied Clinical Trials
Despite ambitions to streamline regulatory review, FDA's Elsa platform has been prone to hallucinations , prompting internal scrutiny and questions ...
Read the original at Applied Clinical Trials ↗
- Topics
- Hallucinations & FabricationHealthcareGovernance & Risk ManagementRegulation & Policy
- Mentions
- FDA
- Tracked via
- “AI hallucination”